Indian drugmaker Wockhardt has achieved a significant milestone with the launch of Zaynich, India’s first fully homegrown novel antibiotic. Developed after years of research, the drug has received approval from the US Food and Drug Administration (FDA), making it the first Indian-discovered and developed medicine to earn such recognition.
Zaynich is designed to combat multidrug-resistant bacterial infections, a growing global health concern. Experts say the new antibiotic could help treat serious infections that no longer respond to existing medicines. The achievement is being seen as a major boost for India’s pharmaceutical innovation, highlighting the country’s ability to move beyond generic drug manufacturing into original drug discovery.